Current Appointments & Affiliations
Biostatistician, Senior
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge.
Journal Article JAMA Cardiol · March 1, 2026 IMPORTANCE: Among patients with heart failure with reduced ejection fraction (HFrEF) in US clinical practice, the residual risk of poor clinical outcomes despite quadruple medical therapy is not well characterized. OBJECTIVE: To evaluate clinical outcomes ... Full text Link to item CiteResidual Risk Despite Quadruple Medical Therapy for Men vs Women Hospitalized for Heart Failure With Reduced Ejection Fraction.
Journal Article JACC Heart Fail · February 2, 2026 Full text Link to item CiteA plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.
Journal Article Future Cardiol · December 2025 Full text Link to item CiteRecent Grants
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
ResearchBiostatistician · Awarded by University of Texas Southwestern Medical Center · 2022 - 2026The Impact of Quality Metrics on Outcomes among Elderly Heart Failure Patients
ResearchStatistician · Awarded by Dartmouth College · 2019 - 2021Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
ResearchStatistician · Awarded by National Institutes of Health · 2020 - 2021View All Grants